Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson's disease

Expert Review of Neurotherapeutics

Volumn 7, Issue 6, 2007, Pages 585-589

  Kenney, Christopher ^a   Fernandez, Hubert H ^b   Okun, Michael S ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BICUCULLINE; LEVODOPA;

AKINESIA; AUTOPSY; BALANCE DISORDER; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN REGION; COGNITIVE DEFECT; DISEASE MODEL; EDITORIAL; ELECTRODE; ELECTROSTIMULATION; GAIT DISORDER; GLOBUS PALLIDUS; HUMAN; NEUROANATOMY; NEUROCHEMISTRY; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PROGRESSIVE SUPRANUCLEAR PALSY; SUBTHALAMIC NUCLEUS; SYMPTOM;

ANIMALS; DEEP BRAIN STIMULATION; GAIT DISORDERS, NEUROLOGIC; HUMANS; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; TREATMENT OUTCOME;

EID: 34250337280     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.7.6.585     Document Type: Editorial

References (42)

1. Elstner K, Selai CE, Trimble MR, Robertson MM. Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome. Acta Psychiatr. Scand. 103(1), 52-59 (2001).
2. Liu W, McIntire K, Kim SH et al. Bilateral subthalamic stimulation improves gait initiation in patients with Parkinson's disease. Gait Posture 23(4), 492-498 (2006).
3. Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 355(9), 896-908 (2006).
4. Rodriguez-Oroz MC, Obeso JA, Lang AE et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128(Pt 10), 2240-2249 (2005).
5. Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. 21(Suppl. 14), S290-S304 (2006).
6. Kumar R, Lang AE, Rodriguez-Oroz MC et al. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology 55(12 Suppl. 6), S34-S39 (2000).
7. Loher TJ, Burgunder JM, Pohle T et al. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J. Neurosurg. 96(5), 844-853 (2002).
8. Koller WC, Lyons KE, Wilkinson SB, Troster AI, Pahwa R. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov. Disord. 16(3), 464-468 (2001).
9. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 45(6), 1375-1382 (1999).
10. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N. Engl. J. Med. 345(13), 956-963 (2001).
11. Krause M, Fogel W, Heck A et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J. Neurol. Neurosurg. Psychiatry 70(4), 464-470 (2001).
12. Volkmann J, Allert N, Voges J et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 56(4), 548-551 (2001).
13. Krack P, Pollak P, Limousin P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 121(Pt 3), 451-457 (1998).
14. Kenney C, Simpson R, Hunter C et al. Short-term and long-term safety of deep brain stimulation for the treatment of movement disorders. J. Neurosurg. 106, 621-625 (2007).
15. Hariz MI. Complications of deep brain stimulation surgery. Mov. Disord. 17(Suppl. 3), S162-S166 (2002).
16. Okun MS, Tagliati M, Pourfar M et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch. Neurol. 62(8), 1250-1255 (2005).
17. Benabid AL, Chabardes S, Seigneuret E. Deep-brain stimulation in Parkinson's disease: long-term efficacy and safety - what happened this year? Curr. Opin. Neurol. 18(6), 623-630 (2005).
18. Weaver FM, Stern MB, Follett K. Deep-brain stimulation in Parkinson's disease. Lancet Neurol. 5(11), 900-901 (2006).
19. Eidelberg E, Walden JG, Nguyen LH. Locomotor control in macaque monkeys. Brain 104(Pt 4), 647-663 (1981).
20. Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci. 27(10), 585-588 (2004).
21. Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 51(4), 540-543 (1988).
22. Semba K, Fibiger HC. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J. Comp. Neurol. 323(3), 387-410 (1992).
23. Shute CC, Lewis PR. The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections. Brain 90(3), 497-520 (1967).
24. Spann BM, Grofova I. Origin of ascending and spinal pathways from the nucleus tegmenti pedunculopontinus in the rat. J. Comp. Neurol. 283(1), 13-27 (1989).
25. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 123(Pt 9), 1767-1783 (2000).
26. Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL. The pedunculopontine nucleus in Parkinson's disease. Ann. Neurol. 26(1), 41-46 (1989).
27. Lee MS, Rinne JO, Marsden CD. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med. J. 41(2), 167-184 (2000).
28. Steininger TL, Rye DB, Wainer BH. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J. Comp. Neurol. 321(4), 515-543 (1992).
29. Munro-Davies LE, Winter J, Aziz TZ, Stein JF. The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia. Exp. Brain Res. 129(4), 511-517 (1999).
30. Matsumura M. The pedunculopontine tegmental nucleus and experimental parkinsonism. A review. J. Neurol. 252(Suppl. 4), IV5-IV12 (2005).
31. Jones DL, Mogenson GJ. Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. Am. J. Physiol. 238(1), R65-R69 (1980).
32. Mogenson GJ, Nielsen M. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behav. Neural Biol. 42(1), 38-51 (1984).
33. Swerdlow N, Koob G. Neuronal substrates for the behavioral output of the nucleus accumbens. Life Sci. 35, 2537-2544 (1984).
34. Garcia-Rill E. The pedunculopontine nucleus. Prog. Neurobiol. 36(5), 363-389 (1991).
35. Dunbar JS, Hitchcock K, Latimer M et al. Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following unilateral ibotenate or quinolinate lesions. Brain Res. 589(2), 194-206 (1992).
36. Jenkinson N, Nandi D, Miall RC, Stein JF, Aziz TZ. Pedunculopontine nucleus stimulation improves akinesia in a parkinsonian monkey. Neuroreport 15(17), 2621-2624 (2004).
37. Nandi D, Aziz TZ, Giladi N, Winter J, Stein JF. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain 125(Pt 11), 2418-2430 (2002).
38. Takada M, Matsumura M, Kojima J et al. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation. Eur. J. Neurosci. 12(5), 1771-1780 (2000).
39. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 16(17), 1883-1887 (2005).
40. Mazzone P, Lozano A, Stanzione P et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 16(17), 1877-1881 (2005).
41. Stefani A, Lozano AM, Peppe A et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain (2007) (Epub ahead of print).
42. Thomas M, Jankovic J, Suteerawattananon M et al. Clinical gait and balance scale (GABS): validation and utilization. J. Neurol. Sci. 217(1), 89-99 (2004)